Solesence, Inc. (SLSN) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals significant issues: declining gross margin and increased operating expenses, leading to a net loss. Management's vague responses in the Q&A, especially on future guidance, amplify uncertainty. Despite some operational improvements and a projected revenue increase, the financial health and lack of clear guidance weigh heavily. The sentiment is negative, reflecting concerns over profitability and strategic clarity.
Key Financial Performance
Revenue $14.5 million, a decrease of 14% year-over-year. The decline was attributed to a general softening in the industry and a shift in consumer behaviors, as well as adjustments in customer inventory levels compared to the third quarter of 2024.
Gross Profit $3.4 million, down from $6.1 million in the third quarter of 2024. The decrease was due to manufacturing operating inefficiencies and facilities improvements.
Gross Margin 23%, compared to 36% in the same period last year. The decline was related to manufacturing inefficiencies and facilities improvements.
Operating Expenses $4.2 million, up from $2.9 million in the third quarter of 2024. The increase was driven by higher employee-related costs, legal costs, allowance for credit loss, severance costs, and costs related to the company's uplisting to NASDAQ in 2025.
Net Loss $1.1 million, compared to net income of $3 million in the third quarter of 2024. The loss was influenced by the factors affecting revenue, gross profit, and operating expenses.
Adjusted EBITDA Loss of $435,000, compared to adjusted EBITDA of $3.6 million in the third quarter of 2024. This reflects the overall decline in profitability due to the aforementioned factors.
Labor Efficiency Average labor cost per unit reduced by close to 25% year-over-year, and Overall Equipment Effectiveness (OEE) performance increased by 10 percentage points. These improvements were achieved through investments in automation, process optimization, and reorganization of the operating schedule.
Inventory Control Revenue from 300 products and over 1,500 raw materials and components now generates approximately $50 million, compared to $8 million from 40 products six years ago. Enhanced material surveillance and control measures have been implemented to address supply chain challenges and improve profitability.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
SPF technology integration: More brands are infusing their products with SPF technology, driven by Solesence's innovations.
Over-the-counter drug products: Solesence's products must meet stringent performance criteria similar to prescription drugs while ensuring consumer satisfaction.
Revenue growth: Despite a 14% year-over-year revenue decrease in Q3 2025, the company remains confident in long-term growth, supported by strategic brand partners.
Market leadership: Solesence is the industry leader in skin health and mineral-based beauty, with over 90 globally issued patents and 8 awards for innovation.
Labor efficiency: Labor cost per unit reduced by 25% year-over-year, with a 10 percentage point increase in Overall Equipment Effectiveness (OEE).
Inventory control: Enhanced material surveillance and control measures implemented to address supply chain challenges.
Facility consolidation: Consolidated three facilities into two, resulting in mid-6-figure annual cost savings.
Leadership transition: Kevin Cureton has taken over as CEO, succeeding Jess Jankowski, to lead the company into its next growth phase.
Organizational restructuring: Reorganized R&D and quality departments into a unified Innovation and Product Integrity Group to improve product design and manufacturing consistency.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Customer Order Cancellations: The risk of customers canceling purchase orders or supply agreements could adversely impact revenue and operational planning.
Demand for Products: Uncertainty in demand for the company's personal care ingredients and formulated products could affect revenue stability.
Competitive Pressures: The impact of competitive products and technology poses a risk to market share and profitability.
Public Health Issues: Possible disruptions in commercial activities due to public health issues could negatively affect operations.
Armed Conflict and Terrorist Activity: Potential disruptions caused by armed conflict or terrorist activity could impact supply chains and operations.
Product Design Challenges: Complex product design requirements, including meeting over-the-counter drug standards, could lead to inefficiencies and increased costs if not managed effectively.
Labor Efficiency: Historical inefficiencies in labor and maintenance have impacted profitability, though recent improvements have been made.
Inventory Control: The increased complexity in managing a larger number of raw materials and products has created challenges in inventory control, potentially affecting profitability.
Revenue Decline: The third quarter of 2025 saw a 14% year-over-year revenue decline, attributed to industry softening and customer inventory adjustments.
Gross Margin Decline: Gross margin decreased from 36% to 23% year-over-year, driven by manufacturing inefficiencies and facility improvements.
Operating Expense Increase: Operating expenses increased due to higher employee-related costs, legal costs, severance, and NASDAQ uplisting expenses.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: The company remains confident in its ability to grow at a multiple of the industry's growth rate and remain highly profitable. This confidence is supported by the growth plans of its strategic brand partners, who expect to outperform the market.
Profitability Improvements: The company has implemented changes in product design, labor efficiency, and inventory control to drive profitability. These include reorganizing teams, automating processes, and consolidating facilities, which are expected to yield significant cost savings and efficiency gains.
Labor Efficiency: Improvements in labor efficiency have led to a 25% reduction in average labor cost per unit and a 10 percentage point increase in Overall Equipment Effectiveness (OEE). These changes are expected to contribute to a high six-figure to low seven-figure reduction in direct labor expenses annually.
Inventory Control: Enhanced material surveillance and control measures have been implemented to address supply chain challenges. These changes aim to reduce variances and improve profitability.
Market Trends: The company’s products are driving revenue for brand partners, representing 30% to 60% of their business volume. Key retail segments include specialty beauty retailers, TikTok, and Amazon.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Are we making the same mistakes over and over again?
A:Kevin Cureton acknowledged that some areas, like inventory management, have taken longer to repair, but changes made in the last quarter are expected to address these issues. He also highlighted that revenue is up $10 million year-over-year, but consumer sentiment and brand partners' conservative inventory levels have impacted lead times and stocking levels.
Q:Why was the third quarter report delayed?
A:Kevin Cureton explained that the new leadership team wanted to ensure the report was done correctly the first time.
Q:Do you expect greater sales reports for the fourth quarter this year?
A:Kevin Cureton stated that they expect an improvement over the prior year on a full-year basis, with positive revenue growth versus 2024.
Q:Will the company continue to make simple mistakes that cause problems?
A:Kevin Cureton disagreed with the characterization of past issues as simple mistakes, particularly regarding the BASF lawsuit, which he described as a commercial point of difference. He acknowledged the importance of details and stated that the company is taking steps to improve operational performance.
Q:What caused the lower gross margin this quarter?
A:Kevin Cureton attributed the lower gross margin to expenses from consolidation that couldn't be capitalized and higher indirect expenses during the transition. Laura Riffner added that they are addressing indirect costs and expect improvements in the next few quarters.
Q:What are the sales and margin forecasts for the fourth quarter and 2026?
A:Kevin Cureton projected $64 million in sales for the year, up $12 million from the prior year. He refrained from giving specific 2026 guidance but stated that 30% gross margin is the floor, not the ceiling. He also mentioned aiming for margins in the 40%-plus range over time.
Q:What is the expected run rate of SG&A expenses?
A:Kevin Cureton stated that the current level of $3 million is expected to continue due to leadership additions and higher legal fees. Jess Jankowski noted a $400,000 one-time severance expense that will not recur, and improvements in doubtful accounts are expected to offset some costs.
Q:Will the company achieve COVID-era margins of 40%?
A:Kevin Cureton stated that achieving 40%-plus margins is an objective, though it will take time. He emphasized the company's technological leadership and improvements in direct and indirect margins.
Q:What does it mean to grow at multiples of the industry in a softening market?
A:Kevin Cureton explained that SPF-infused beauty, particularly mineral-based products, is growing faster than the overall beauty industry. The company's technological leadership and consumer preferences for mineral-based SPF products position it to grow at a multiple of the industry's growth rate.
Q:What is the impact of the ERC payment on the financials?
A:Laura Riffner confirmed that the ERC payment was included in the third quarter of 2025 and impacted the bottom line for that quarter.
Q:Review of Unclear Management Responses
A:Management avoided providing specific guidance for 2026 sales and margins, citing market uncertainty. They also used vague language when discussing operational improvements and future margin targets, offering limited details on how they plan to achieve 40%-plus margins.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Amazon class
CEW innovator
Chief Executive
Conference Instructions
Cosmetic Executive
Effectiveness OEE
Executive Officer
Group
President Chief
Product Integrity
beauty product
capability
capacity
change scope
confidence
consumer beauty
criterion
decade
drug product
figure reduction
inventory control
investment
journey
labor efficiency
leader
material component
mineral
product design
product material
reduction labor
scope scale
structure
surveillance
vision
year product
SLSN Transcript
Solesence, Inc. (SLSN) Q3 2025 Earnings Call Transcript
Unknown11-11
The earnings call reveals significant issues: declining gross margin and increased operating expenses, leading to a net loss. Management's vague responses in the Q&A, especially on future guidance, amplify uncertainty. Despite some operational improvements and a projected revenue increase, the financial health and lack of clear guidance weigh heavily. The sentiment is negative, reflecting concerns over profitability and strategic clarity.
Solesence, Inc. (SLSN) Q1 2025 Earnings Conference Call Transcript
Positive5-6
The earnings call highlights record revenues, a successful new product launch, and a strong demand pipeline, which are positive indicators. The gross margin decline is attributed to one-time costs, with expectations for improvement. Although there's no shareholder return plan, the company's strategic initiatives, such as securing new patents and improving operations, are promising. The Q&A reveals some concerns over operational issues, but management's corrective measures and strong future revenue expectations suggest a positive outlook, likely resulting in a stock price increase of 2% to 8%.
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
